“BrainSee unlocks value from brain MRI by providing objective measures for doctors’ prognosis of Alzheimer’s. With FDA approval, Darmiyan will facilitate better patient monitoring and precision medicine.”

BrainSee will be helpful for motivating people to stay the course with the personalized Precision Medicine protocols I use to reverse cognitive decline.

“I look forward to making BrainSee widely available, an imaginative new method for noninvasively illuminating and detecting Alzheimer’s at stages where intervention might be possible.”